Significant adverse events and outcomes after medical abortion.

@article{Cleland2013SignificantAE,
  title={Significant adverse events and outcomes after medical abortion.},
  author={Kelly Cleland and Mitchell D Creinin and Deborah L. Nucatola and Montsine Nshom and James Trussell},
  journal={Obstetrics and gynecology},
  year={2013},
  volume={121 1},
  pages={
          166-71
        }
}
OBJECTIVE To analyze rates of significant adverse events and outcomes in women having a medical abortion at Planned Parenthood health centers in 2009 and 2010 and to identify changes in the rates of adverse events and outcomes between the 2 years. METHODS In this database review we analyzed data from Planned Parenthood affiliates that provided medical abortion in 2009 and 2010 almost exclusively using an evidence-based buccal misoprostol regimen. We evaluated the incidence of six clinically… CONTINUE READING

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

Medical Abortion.

  • Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Medical Abortion: Use of Mifepristone and Misoprostol in First and Second Trimesters of Pregnancy

  • Current Obstetrics and Gynecology Reports
  • 2015
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Abortion through telemedicine.

  • Current opinion in obstetrics & gynecology
  • 2018

Misoprostol in Abortion Care: Review and Update

  • Current Obstetrics and Gynecology Reports
  • 2017
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Medication abortion.

  • Clinical obstetrics and gynecology
  • 2009

bulletin 67: Medical management of abortion

ACOG. Practic
  • Obstet Gynecol.
  • 2005
VIEW 1 EXCERPT

Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial

Y Wu, M Gomez-Alzugaray, +3 authors A Pretnar-Darovec
  • Br J Obstet Gynaecol
  • 2000
VIEW 1 EXCERPT

Epidemiological assessment of misoprostol teratogenicity.

  • BJOG : an international journal of obstetrics and gynaecology
  • 2000
VIEW 1 EXCERPT